BioPharma Credit (LON:BPCP) Shares Down 1.7% – Here’s What Happened

BioPharma Credit PLC (LON:BPCPGet Free Report)’s stock price traded down 1.7% during mid-day trading on Thursday . The stock traded as low as GBX 65.65 ($0.85) and last traded at GBX 65.68 ($0.85). 6,709 shares traded hands during trading, a decline of 72% from the average session volume of 23,857 shares. The stock had previously closed at GBX 66.80 ($0.87).

BioPharma Credit Stock Performance

The company has a fifty day simple moving average of GBX 68.83 and a 200 day simple moving average of GBX 69.65. The stock has a market capitalization of £899.82 million, a price-to-earnings ratio of 1,094.67 and a beta of 0.22.

BioPharma Credit Company Profile

(Get Free Report)

BioPharma Credit PLC, an investment trust, primarily invests in interest-bearing debt assets. Its debt assets are secured by royalties or other cash flows derived from the sales of approved life sciences products. BioPharma Credit PLC was incorporated in 2016 and is based in London, the United Kingdom.

Further Reading

Receive News & Ratings for BioPharma Credit Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioPharma Credit and related companies with MarketBeat.com's FREE daily email newsletter.